Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             171 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A case of linear immunoglobulin A bullous dermatosis in a patient exposed to sun and an analgesic Pellicano, Riccardo
 2009
 31 Part 2 p. 1987-1990
4 p.
 artikel
2 A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: A prospective cohort study Li, Xiayu
 2009
 31 Part 2 p. 741-750
10 p.
 artikel
3 A comparison of insulin use, glycemic control, and health care costs with insulin detemir and insulin glargine in insulin-naive patients with type 2 diabetes Borah, Bijan J.
 2009
 31 Part 2 p. 623-631
9 p.
 artikel
4 A multicenter, randomized, double-blind, placebo- controlled trial of intravenous ibuprofen 400 and 800 mg every 6 hours in the management of postoperative pain Southworth, Stephen
 2009
 31 Part 2 p. 1922-1935
14 p.
 artikel
5 Analysis of the North Carolina Long-Term Care Polypharmacy Initiative: A multiple-cohort approach using propensity-score matching for both evaluation and targeting Trygstad, Troy K.
 2009
 31 Part 2 p. 2018-2037
20 p.
 artikel
6 Anemia, hypoalbuminemia, and renal impairment as predictors of bleeding complications in patients receiving anticoagulation therapy for nonvalvular atrial fibrillation: A secondary analysis Abdelhafiz, Ahmed H.
 2009
 31 Part 2 p. 1534-1539
6 p.
 artikel
7 An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists van Roon, Eric N.
 2009
 31 Part 2 p. 1737-1746
10 p.
 artikel
8 An open-label, single-dose, parallel-group, dose-increasing study comparing the pharmacokinetics and tolerability of pilsicainide hydrochloride in healthy Korean and Japanese male subjects Kim, Bo-Hyung
 2009
 31 Part 2 p. 609-618
10 p.
 artikel
9 An oral sulfonylurea in the treatment of transient neonatal diabetes mellitus Loomba-Albrecht, Lindsey A.
 2009
 31 Part 2 p. 816-820
5 p.
 artikel
10 Anthracycline- and/or taxane-resistant breast cancer: Results of a literature review to determine the clinical challenges and current treatment trends Moreno-Aspitia, Alvaro
 2009
 31 Part 2 p. 1619-1640
22 p.
 artikel
11 Antidiabetic medication use and prevalence of chronic kidney disease among patients with type 2 diabetes mellitus in the United States Koro, Carol E.
 2009
 31 Part 2 p. 2608-2617
10 p.
 artikel
12 Antipsychotics and antidepressants: An analysis of cost growth in finland from 1999 to 2005 Koskinen, Hanna
 2009
 31 Part 2 p. 1469-1477
9 p.
 artikel
13 A pharmacokinetic comparison of single doses of once-daily cyclobenzaprine extended-release 15 mg and 30 mg: A randomized, double-blind, two-period crossover study in healthy volunteers Darwish, Mona
 2009
 31 Part 2 p. 108-114
7 p.
 artikel
14 A randomized, controlled study comparing a lidocaine patch, a placebo patch, and anesthetic injection for treatment of trigger points in patients with myofascial pain syndrome: Evaluation of pain and somatic pain thresholds Affaitati, Giannapia
 2009
 31 Part 2 p. 705-720
16 p.
 artikel
15 A review of efficacy and safety data regarding the use of liraglutide, a once-daily human glucagon-like peptide 1 analogue, in the treatment of type 2 diabetes mellitus Montanya, Eduard
 2009
 31 Part 2 p. 2472-2488
17 p.
 artikel
16 A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis Bachert, Claus
 2009
 31 Part 2 p. 921-944
24 p.
 artikel
17 A review of three stand-alone topical thrombins for surgical hemostasis Cheng, Christine M.
 2009
 31 Part 2 p. 32-41
10 p.
 artikel
18 A review of tolerability and abuse liability of γ-hydroxybutyric acid for insomnia in patients with schizophrenia Kantrowitz, Joshua T.
 2009
 31 Part 2 p. 1360-1373
14 p.
 artikel
19 Arterial wave reflection during antihypertensive therapy with barnidipine: A 6-month, open-label study using an integrated cardiovascular ultrasound approach in patients with newly diagnosed hypertension Palombo, Carlo
 2009
 31 Part 2 p. 2873-2885
13 p.
 artikel
20 A single-center, open-label, one-sequence study of dalcetrapib coadministered with ketoconazole, and an in vitro study of the S-methyl metabolite of dalcetrapib Derks, Michael
 2009
 31 Part 2 p. 586-599
14 p.
 artikel
21 A single-dose, randomized, two-way crossover study comparing two olanzapine tablet products in healthy adult male volunteers under fasting conditions Elshafeey, Ahmed H.
 2009
 31 Part 2 p. 600-608
9 p.
 artikel
22 A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions Marcelín-Jiménez, Gabriel
 2009
 31 Part 2 p. 2002-2011
10 p.
 artikel
23 Assessment of the bioequivalence of brand and biogeneric formulations of abciximab for the treatment of acute coronary syndrome: A prospective, open-label, randomized, controlled study in Korean patients Choi, Dong-Hyun
 2009
 31 Part 2 p. 1804-1811
8 p.
 artikel
24 Association between previous health care use and initiation of inhaled corticosteroid and long-acting β2-adrenergic agonist combination therapy among US patients with asthma Blanchette, Christopher M.
 2009
 31 Part 2 p. 2574-2583
10 p.
 artikel
25 Author index 2009 2009
 31 Part 2 p. 3025-3031
7 p.
 artikel
26 Bendamustine for the treatment of chronic lymphocytic leukemia and rituximab-refractory, indolent B-cell non-hodgkin lymphoma Dennie, Trevor W.
 2009
 31 Part 2 p. 2290-2311
22 p.
 artikel
27 Besifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: A multicenter, prospective, randomized, double-masked, vehicle-controlled, 5-day efficacy and safety study Karpecki, Paul
 2009
 31 Part 2 p. 514-526
13 p.
 artikel
28 Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: An open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers Rhim, Si-Youn
 2009
 31 Part 2 p. 1037-1045
9 p.
 artikel
29 Bioavailability of two oral formulations of a single dose of levofloxacin 500 mg: An open-label, randomized, two-period crossover comparison in healthy mexican volunteers Galan-Herrera, Juan Francisco
 2009
 31 Part 2 p. 1796-1803
8 p.
 artikel
30 Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): Single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects Palma-Aguirre, Jose Antonio
 2009
 31 Part 2 p. 399-410
12 p.
 artikel
31 Bioequivalence and tolerability of two clopidogrel salt preparations, besylate and bisulfate: A randomized, open-label, crossover study in healthy Korean male subjects Kim, Sung-Doo
 2009
 31 Part 2 p. 793-803
11 p.
 artikel
32 Bioequivalence of a single 10-mg dose of finasteride 5-mg oral disintegrating tablets and standard tablets in healthy adult male Han Chinese volunteers: A randomized sequence, open-label, two-way crossover study Chen, Li
 2009
 31 Part 2 p. 2242-2248
7 p.
 artikel
33 Bioequivalence of generic and branded subcutaneous enoxaparin: A single-dose, randomized-sequence, open-label, two-period crossover study in healthy Chinese male subjects Feng, Limin
 2009
 31 Part 2 p. 1559-1567
9 p.
 artikel
34 Bioequivalence of single and multiple doses of venlafaxine extended-release tablets and capsules in the fasted and fed states: Four open-label, randomized crossover trials in healthy volunteers Wright, Clinton W.
 2009
 31 Part 2 p. 2722-2734
13 p.
 artikel
35 Bioequivalence of single 100-mg doses of two oral formulations of topiramate: An open-label, randomized-sequence, two-period crossover study in healthy adult male Mexican volunteers Piñeyro-López, Alfredo
 2009
 31 Part 2 p. 411-417
7 p.
 artikel
36 Bioequivalence of two film-coated tablets of imatinib mesylate 400 mg: A randomized, open-label, single-dose, fasting, two-period, two-sequence crossover comparison in healthy male South American volunteers Parrillo-Campiglia, Susana
 2009
 31 Part 2 p. 2224-2232
9 p.
 artikel
37 Bioequivalence of two formulations of glucosamine sulfate 500-mg capsules in healthy male chinese volunteers: An open-label, randomized-sequence, single-dose, fasting, two-way crossover study Zhu, YuBing
 2009
 31 Part 2 p. 1551-1558
8 p.
 artikel
38 Bioequivalence of zonisamide orally dispersible tablet and immediate-release capsule formulations: Results from two open-label, randomized-sequence, single-dose, two-period, two-treatment crossover studies in healthy male volunteers Maanen, Rob van
 2009
 31 Part 2 p. 1244-1255
12 p.
 artikel
39 Celecoxib in the treatment of primary dysmenorrhea: Results from two randomized, double-blind, active- and placebo-controlled, crossover studies Daniels, Stephen
 2009
 31 Part 2 p. 1192-1208
17 p.
 artikel
40 Certolizumab pegol for the management of Crohn's disease in adults Rivkin, Anastasia
 2009
 31 Part 2 p. 1158-1176
19 p.
 artikel
41 Changes in physicians' practice of prescribing cyclooxygenase-2 inhibitor after market withdrawal of rofecoxib: A retrospective study of physician-patient pairs in Taiwan Hsiao, Fei-Yuan
 2009
 31 Part 2 p. 2618-2627
10 p.
 artikel
42 Clinically significant drug—drug interactions between oral anticancer agents and nonanticancer agents: A delphi survey of oncology pharmacists Chan, Alexandre
 2009
 31 Part 2 p. 2379-2386
8 p.
 artikel
43 Colesevelam hydrochloride for the treatment of type 2 diabetes mellitus Sonnett, Travis E.
 2009
 31 Part 2 p. 245-259
15 p.
 artikel
44 Comparative clinical trial of S-adenosylmethionine versus nabumetone for the treatment of knee osteoarthritis: An 8-week, multicenter, randomized, double-blind, double-dummy, Phase IV study in Korean patients Kim, Jinhyun
 2009
 31 Part 2 p. 2860-2872
13 p.
 artikel
45 Comparative pharmacokinetic evaluation of two formulations of bicalutamide 50-mg tablets: An open-label, randomized-sequence, single-dose, two-period crossover study in healthy Korean male volunteers Lee, SeungHwan
 2009
 31 Part 2 p. 3000-3008
9 p.
 artikel
46 Comparison of temsirolimus pharmacokinetics in patients with renal cell carcinoma not receiving dialysis and those receiving hemodialysis: A case series Lunardi, Gianluigi
 2009
 31 Part 2 p. 1812-1819
8 p.
 artikel
47 Comparison of the effect of antibiotic treatment on the possibility of diagnosing invasive pneumococcal disease by culture or molecular methods: A prospective, observational study of children and adolescents with proven pneumococcal infection Resti, Massimo
 2009
 31 Part 2 p. 1266-1273
8 p.
 artikel
48 Comparison of the effects of once-monthly versus once-daily risedronate in postmenopausal osteoporosis: A phase II, 6-month, multicenter, randomized, double-blind, active-controlled, dose-ranging study Ste-Marie, Louis-Georges
 2009
 31 Part 2 p. 272-285
14 p.
 artikel
49 Comparison of the efficacy and safety of arformoterol 15 μg twice daily and arformoterol 30 μg once daily in COPD: A single-dose, multicenter, randomized, modified-blind, two-way crossover study Panettieri Jr., Reynold A.
 2009
 31 Part 2 p. 1716-1723
8 p.
 artikel
50 Comparison of the pharmacokinetics of sulfamethoxazole in male chinese volunteers at low altitude and acute exposure to high altitude versus subjects living chronically at high altitude: An open-label, controlled, prospective study Li, Xiang-Yang
 2009
 31 Part 2 p. 2744-2754
11 p.
 artikel
51 Comparison of the pharmacokinetics of ticlopidine between administration of a combined fixed-dose tablet formulation of ticlopidine 250 mg/Ginkgo extract 80 mg, and concomitant administration of ticlopidine 250-mg and ginkgo extract 80-mg tablets: An open-label, two-treatment, single-dose, randomized-sequence crossover study in healthy Korean male volunteers Kim, Tae-Eun
 2009
 31 Part 2 p. 2249-2257
9 p.
 artikel
52 Considerations for pregnant patients with Gaucher disease: Challenges for the patient and physician Belmatoug, Nadia
 2009
 31 Part 2 p. S192-S193
2 p.
 artikel
53 Cost-effectiveness analysis of micafungin versus fluconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplantation in Korea Sohn, Hyun Soon
 2009
 31 Part 2 p. 1105-1115
11 p.
 artikel
54 Cost-effectiveness of quetiapine plus mood stabilizers compared with mood stabilizers alone in the maintenance therapy of bipolar I disorder: Results of a markov model analysis Fajutrao, Liberty
 2009
 31 Part 2 p. 1456-1468
13 p.
 artikel
55 Cost-minimization analysis of sequence changes between FOLFIRI and FOLFOX6 therapy for advanced colorectal cancer in Japan Miyazaki, Yoshiko
 2009
 31 Part 2 p. 2433-2441
9 p.
 artikel
56 Cost-related prescription nonadherence in the united states and Canada: A system-level comparison using the 2007 international health policy survey in seven countries Kennedy, Jae
 2009
 31 Part 2 p. 213-219
7 p.
 artikel
57 Current and emerging therapies for acute myeloid leukemia Robak, Tadeusz
 2009
 31 Part 2 p. 2349-2370
22 p.
 artikel
58 Degarelix: A gonadotropin-releasing hormone antagonist for the management of prostate cancer Steinberg, Michael
 2009
 31 Part 2 p. 2312-2331
20 p.
 artikel
59 Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: An 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies Tourian, Karen A.
 2009
 31 Part 2 p. 1405-1423
19 p.
 artikel
60 Development of novel therapies in murine models for Gaucher disease Enquist, Ida Berglin
 2009
 31 Part 2 p. S198-S199
2 p.
 artikel
61 Diclofenac potassium liquid-filled soft gelatin capsules in the management of patients with postbunionectomy pain: A phase III, multicenter, randomized, double-blind, placebo-controlled study conducted over 5 days Riff, Dennis S.
 2009
 31 Part 2 p. 2072-2085
14 p.
 artikel
62 Differences in annual medication costs and rates of dosage increase between tumor necrosis factor-antagonist therapies for rheumatoid arthritis in a managed care population Ollendorf, Daniel A.
 2009
 31 Part 2 p. 825-835
11 p.
 artikel
63 Drug rash with eosinophilia and systemic signs syndrome in a patient with multiple sclerosis Caruso, Angelo
 2009
 31 Part 2 p. 580-584
5 p.
 artikel
64 Economic evaluation of dabigatran etexilate for the prevention of venous thromboembolism after total knee and hip replacement surgery Wolowacz, Sorrel E.
 2009
 31 Part 2 p. 194-212
19 p.
 artikel
65 Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: Results from an analysis of data from a US claims database Pelletier, Elise M.
 2009
 31 Part 2 p. 2653-2664
12 p.
 artikel
66 Effectiveness and tolerability of colesevelam hydrochloride for bile-acid malabsorption in patients with cancer: A retrospective chart review and patient questionnaire Wedlake, Linda
 2009
 31 Part 2 p. 2549-2558
10 p.
 artikel
67 Effectiveness and tolerability of pharmacologic and combined interventions for reducing injection pain during routine childhood immunizations: Systematic review and meta-analyses Shah, Vibhuti
 2009
 31 Part 2 p. S104-S151
48 p.
 artikel
68 Effectiveness of hydralazine/isosorbide dinitrate in racial/ethnic subgroups with heart failure Hammermeister, Karl E.
 2009
 31 Part 2 p. 632-643
12 p.
 artikel
69 Effect of agalsidase alfa replacement therapy on fabry disease—related hypertrophic cardiomyopathy: A 12- to 36-month, retrospective, blinded echocardiographic pooled analysis Kampmann, Christoph
 2009
 31 Part 2 p. 1966-1976
11 p.
 artikel
70 Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion Raz, Itamar
 2009
 31 Part 2 p. 980-987
8 p.
 artikel
71 Effect of the CYP3A inhibitor ketoconazole on the pharmacokinetics and pharmacodynamics of bortezomib in patients with advanced solid tumors: A prospective, multicenter, open-label, randomized, two-way crossover drug—drug interaction study Venkatakrishnan, Karthik
 2009
 31 Part 2 p. 2444-2458
15 p.
 artikel
72 Effects of a concomitant single oral dose of rifampicin on the pharmacokinetics of pravastatin in a two-phase, randomized, single-blind, placebo-controlled, crossover study in healthy Chinese male subjects Deng, Sheng
 2009
 31 Part 2 p. 1256-1263
8 p.
 artikel
73 Effects of combination treatment with ketoprofen 100 mg + acetaminophen 1000 mg on postoperative dental pain: A single-dose, 10-hour, randomized, double-blind, active- and placebo-controlled clinical trial Akural, Ethem I.
 2009
 31 Part 2 p. 560-568
9 p.
 artikel
74 Effects of fluoxetine on fine motor performance in dysthymia: An 8-week, nonrandomized, open-label study Schrijvers, Didier
 2009
 31 Part 2 p. 123-129
7 p.
 artikel
75 Effects of food intake on the pharmacokinetics of diclofenac potassium soft gelatin capsules: A single-dose, randomized, two-way crossover study Scallion, Ralph
 2009
 31 Part 2 p. 2233-2241
9 p.
 artikel
76 Effects of hepatic impairment on the pharmacokinetics of nilotinib: An open-label, single-dose, parallel-group study Yin, Ophelia Q.P.
 2009
 31 Part 2 p. 2459-2469
11 p.
 artikel
77 Effects of intravenous patient-controlled analgesia with buprenorphine and morphine alone and in combination during the first 12 postoperative hours: A randomized, double-blind, four-arm trial in adults undergoing abdominal surgery Oifa, Stanislav
 2009
 31 Part 2 p. 527-541
15 p.
 artikel
78 Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment of seasonal allergie rhinitis: A phase III, multicenter, randomized, double-blind, active- and placebo-controlled study in adolescents and adults Shah, Shailen R.
 2009
 31 Part 2 p. 99-107
9 p.
 artikel
79 Effects of oral posaconazole on the pharmacokinetic properties of oral and intravenous midazolam: A phase I, randomized, open-label, crossover study in healthy volunteers Krishna, Gopal
 2009
 31 Part 2 p. 286-298
13 p.
 artikel
80 Effects of pitavastatin on cerebral blood flow Horimoto, Yoshihiko
 2009
 31 Part 2 p. 575-579
5 p.
 artikel
81 Effects of treatment with etizolam 0.5 mg BID on cognitive performance: A 3-week, multicenter, randomized, double-blind, placebo-controlled, two-treatment, three-period, noninferiority crossover study in patients with anxiety disorder De Candia, Maria Pia
 2009
 31 Part 2 p. 2851-2859
9 p.
 artikel
82 Efficacy and safety of low-dose transdermal buprenorphine patches (5, 10, and 20 μg/h) versus prolonged-release tramadol tablets (75, 100, 150, and 200 mg) in patients with chronic osteoarthritis pain: A 12-week, randomized, open-label, controlled, parallel-group noninferiority study Karlsson, Mats
 2009
 31 Part 2 p. 503-513
11 p.
 artikel
83 Efficacy and tolerability of intranasal fentanyl spray 50 to 200 μg for breakthrough pain in patients with cancer: A phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period Kress, Hans Georg
 2009
 31 Part 2 p. 1177-1191
15 p.
 artikel
84 Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: A retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension Germino, F. Wilford
 2009
 31 Part 2 p. 1946-1956
11 p.
 artikel
85 Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: A 10-day, phase III, randomized, double-blind, active- and placebo-controlled study Hartrick, Craig
 2009
 31 Part 2 p. 260-271
12 p.
 artikel
86 Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: An 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial Kim, Sang-Hyun
 2009
 31 Part 2 p. 988-998
11 p.
 artikel
87 Efficacy of a single dose of live attenuated influenza vaccine in previously unvaccinated children: A post hoc analysis of three studies of children aged 2 to 6 years Block, Stan L.
 2009
 31 Part 2 p. 2140-2147
8 p.
 artikel
88 Estimated annual direct expenditures in the united states as a result of inappropriate hypertension treatment according to national treatment guidelines Balu, Sanjeev
 2009
 31 Part 2 p. 1581-1594
14 p.
 artikel
89 Etravirine: A second-generation nonnucleoside reverse transcriptase inhibitor (NNRTI) active against NNRTI-resistant strains of HIV Schiller, Daryl S.
 2009
 31 Part 2 p. 692-704
13 p.
 artikel
90 Evaluation of a compliance device in a subgroup of adult patients receiving specific immunotherapy with grass allergen tablets (GRAZAX®) in a randomized, open-label, controlled study: An a priori subgroup analysis Jansen, Ad
 2009
 31 Part 2 p. 321-327
7 p.
 artikel
91 Evaluation of the dose—response relationship of aliskiren, a direct renin inhibitor, in an 8-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled study in adult patients with stage 1 or 2 essential hypertension Puig, Juan G.
 2009
 31 Part 2 p. 2839-2850
12 p.
 artikel
92 Exenatide added to insulin therapy: A retrospective review of clinical practice over two years in an academic endocrinology outpatient setting Yoon, Nancy M.
 2009
 31 Part 2 p. 1511-1523
13 p.
 artikel
93 Fatal acute hepatitis after sequential treatment with levofloxacin, doxycycline, and naproxen in a patient presenting with acute Mycoplasma pneumoniae infection Carrascosa, Miguel F.
 2009
 31 Part 2 p. 1014-1019
6 p.
 artikel
94 First-year treatment adherence among outpatients initiating antihypertensive medication in Korea: Results of a retrospective claims review Sung, Si-Kyung
 2009
 31 Part 2 p. 1309-1320
12 p.
 artikel
95 Focus on hematologic abnormalities and pathophysiologic mechanisms in Gaucher disease Zimran, Ari
 2009
 31 Part 2 p. S171-S172
2 p.
 artikel
96 Gabapentin for the treatment of hot flashes in women with natural or tamoxifen-induced menopause: A systematic review and meta-analysis Toulis, Konstantinos A.
 2009
 31 Part 2 p. 221-235
15 p.
 artikel
97 Gastroprotective drugs in Australia: Utilization patterns between 1997 and 2006 in relation to NSAID prescribing Barozzi, Nadia
 2009
 31 Part 2 p. 849-861
13 p.
 artikel
98 High-dose estrogen as salvage hormonal therapy for highly refractory metastatic breast cancer: A retrospective chart review Mahtani, Reshma L.
 2009
 31 Part 2 p. 2371-2378
8 p.
 artikel
99 Identification of patients receiving peritoneal dialysis using health insurance claims data Berger, Ariel
 2009
 31 Part 2 p. 1321-1334
14 p.
 artikel
100 Impact of illegal trade on the quality of epoetin alfa in Thailand Fotiou, Fotis
 2009
 31 Part 2 p. 336-346
11 p.
 artikel
101 Impact of long-term statin treatment on coronary plaque composition at angiographically severe lesions: A nonrandomized study of the history of long-term statin treatment before coronary angioplasty Miyagi, Motohiro
 2009
 31 Part 2 p. 64-73
10 p.
 artikel
102 Improving compliance and quality of life with home infusions for the treatment of fabry disease Cousins, Alison J.
 2009
 31 Part 2 p. S12-S13
2 p.
 artikel
103 Inadequate pain management during routine childhood immunizations: The nerve of it Taddio, Anna
 2009
 31 Part 2 p. S152-S167
16 p.
 artikel
104 Influence of alcohol on the hemodynamic effects and pharmacokinetic properties of mirodenafil: A single-dose, randomized-sequence, open-label, crossover study in healthy male volunteers in Korea Kim, Bo-Hyung
 2009
 31 Part 2 p. 1234-1243
10 p.
 artikel
105 Inhaled corticosteroids or long-acting β-agonists alone or in fixed-dose combinations in asthma treatment: A systematic review of fluticasone/budesonide and formoterol/salmeterol Frois, Christian
 2009
 31 Part 2 p. 2779-2803
25 p.
 artikel
106 Lapatinib: A small-molecule inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor—2 tyrosine kinases used in the treatment of breast cancer Tevaarwerk, Amye J.
 2009
 31 Part 2 p. 2332-2348
17 p.
 artikel
107 Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children Singh-Franco, Devada
 2009
 31 Part 2 p. 1664-1687
24 p.
 artikel
108 Long-term follow-up of the original interferon-β1b trial in multiple sclerosis: Design and lessons from a 16-year observational study Ebers, George C.
 2009
 31 Part 2 p. 1724-1736
13 p.
 artikel
109 Lost in translation: Differences in antimicrobial indication approval policies between the United States and Europe Pappas, Georgios
 2009
 31 Part 2 p. 1595-1603
9 p.
 artikel
110 Low doses of transdermal buprenorphine in opioid-naive patients with cancer pain: A 4-week, nonrandomized, open-label, uncontrolled observational study Mercadante, Sebastiano
 2009
 31 Part 2 p. 2134-2138
5 p.
 artikel
111 Market uptake of biologic and small-molecule—Targeted oncology drugs in Europe Obradovic, Marko
 2009
 31 Part 2 p. 2940-2952
13 p.
 artikel
112 Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: A multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trial Orlikowski, David
 2009
 31 Part 2 p. 1765-1773
9 p.
 artikel
113 Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia Sorensen, Sonja V.
 2009
 31 Part 2 p. 862-879
18 p.
 artikel
114 Modeling the impact of a new vaccine on pneumococcal and nontypable Haemophilus influenzae diseases: A new simulation model De Wals, Philippe
 2009
 31 Part 2 p. 2152-2169
18 p.
 artikel
115 Modified visual analog scale symptom-intensity and overall-bother measures for the assessment of symptoms in studies of pharmacologic stress agents Harding, Gale
 2009
 31 Part 2 p. 889-901
13 p.
 artikel
116 Nebivolol: A third-generation β-blocker for hypertension Cheng, Judy W.M.
 2009
 31 Part 2 p. 447-462
16 p.
 artikel
117 Neutralization of α2-antiplasmin by microplasmin: A randomized, double-blind, placebo-controlled, ascending-dose study in healthy male volunteers Pakola, Steve
 2009
 31 Part 2 p. 1688-1706
19 p.
 artikel
118 Nilotinib for imatinib-resistant or -intolerant chronic myeloid leukemia in chronic phase, accelerated phase, or blast crisis: A single- and multiple-dose, open-label pharmacokinetic study in Chinese patients Zhou, Li
 2009
 31 Part 2 p. 1568-1575
8 p.
 artikel
119 N-of-1 double-blind, randomized controlled trial of tramadol to treat chronic cough Louly, Priscila Gebrim
 2009
 31 Part 2 p. 1007-1013
7 p.
 artikel
120 Once-monthly oral ibandronate in postmenopausal osteoporosis: Translation and updated review Rossini, Maurizio
 2009
 31 Part 2 p. 1497-1510
14 p.
 artikel
121 Oxymorphone extended release for the treatment of chronic low back pain: A retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use Peniston, John H.
 2009
 31 Part 2 p. 347-359
13 p.
 artikel
122 Pharmacokinetic and bioequivalence comparison between orally disintegrating and conventional tablet formulations of flurbiprofen: A single-dose, randomized-sequence, open-label, two-period crossover study in healthy chinese male volunteers Liu, Yan-Mei
 2009
 31 Part 2 p. 1787-1795
9 p.
 artikel
123 Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: A single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers Kim, Bo-Hyung
 2009
 31 Part 2 p. 2755-2764
10 p.
 artikel
124 Pharmacokinetic, pharmacodynamic, efficacy, and safety data from two randomized, double-blind studies in patients with asthma and an in vitro study comparing two dry-powder inhalers delivering a combination of salmeterol 50 μg and fluticasone propionate 250 μg: Implications for establishing bioequivalence of inhaled products Daley-Yates, Peter T.
 2009
 31 Part 2 p. 370-385
16 p.
 artikel
125 Pharmacokinetic—pharmacodynamic interaction between nebicapone and controlled-release levodopa/benserazide: A single-center, phase I, double-blind, randomized, placebo-controlled, four-way crossover study in healthy subjects Nunes, Teresa
 2009
 31 Part 2 p. 2258-2271
14 p.
 artikel
126 Pharmacokinetic properties and bioequivalence of two formulations of arbidol: An open-label, single-dose, randomized-sequence, two-period crossover study in healthy chinese male volunteers Liu, Ming-Yan
 2009
 31 Part 2 p. 784-792
9 p.
 artikel
127 Pharmacokinetics and bioequivalence evaluation of two formulations of 10-mg amlodipine besylate: An open-label, single-dose, randomized, two-way crossover study in healthy chinese male volunteers Liu, Yun
 2009
 31 Part 2 p. 777-783
7 p.
 artikel
128 Pharmacokinetics and bioequivalence of two formulations of rebamipide 100-mg tablets: A randomized, single-dose, two-period, two-sequence crossover study in healthy Korean male volunteers Cho, Hea-Young
 2009
 31 Part 2 p. 2712-2721
10 p.
 artikel
129 Pharmacokinetics, bioequivalence, tolerability, and effects on platelet counts of two formulations of anagrelide in healthy volunteers and patients with thrombocythemia associated with chronic myeloproliferation Petrides, Petro E.
 2009
 31 Part 2 p. 386-398
13 p.
 artikel
130 Pharmacokinetics of a Once-Daily extended-release formulation of pramipexole in healthy male volunteers: Three studies Jenner, Peter
 2009
 31 Part 2 p. 2698-2711
14 p.
 artikel
131 Pharmacokinetics of ciclesonide and desisobutyryl ciclesonide after administration via aqueous nasal spray or hydrofluoroalkane nasal aerosol compared with orally inhaled ciclesonide: An open-label, single-dose, three-period crossover study in healthy volunteers Nave, Ruediger
 2009
 31 Part 2 p. 2988-2999
12 p.
 artikel
132 Pharmacokinetics of conivaptan hydrochloride, a vasopressin V1A/V2-receptor antagonist, in patients with euvolemic or hypervolemic hyponatremia and with or without congestive heart failure from a prospective, 4-day open-label study Mao, Zhongping Lily
 2009
 31 Part 2 p. 1542-1550
9 p.
 artikel
133 Pharmacokinetics of 14C-radioactivity after oral intake of a single dose of 14C-labeled fampridine (4-aminopyridine) in healthy volunteers Blight, Andrew R.
 2009
 31 Part 2 p. 328-335
8 p.
 artikel
134 Pharmacokinetics, safety, and tolerability of varenicline in healthy adolescent smokers: A multicenter, randomized, double-blind, placebo-controlled, parallel-group study Faessel, Helene
 2009
 31 Part 2 p. 177-189
13 p.
 artikel
135 Pharmacokinetic, tolerability, and bioequivalence comparison of three different intravenous formulations of recombinant human erythropoietin in healthy Korean adult male volunteers: An open-label, randomized-sequence, three-treatment, three-way crossover study Cho, Sang-Heon
 2009
 31 Part 2 p. 1046-1053
8 p.
 artikel
136 Pharmacology and tolerability of a single dose of exenatide in adolescent patients with type 2 diabetes mellitus being treated with metformin: A randomized, placebo-controlled, single-blind, dose-escalation, crossover study Malloy, Jaret
 2009
 31 Part 2 p. 806-815
10 p.
 artikel
137 Physical interventions and injection techniques for reducing injection pain during routine childhood immunizations: Systematic review of randomized controlled trials and quasi-randomized controlled trials Taddio, Anna
 2009
 31 Part 2 p. S48-S76
29 p.
 artikel
138 Potential interactions between cilostazol and probucol: A two-part, single-dose, open-label study in healthy Korean male volunteers Kim, Kyu-pyo
 2009
 31 Part 2 p. 2098-2106
9 p.
 artikel
139 Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: Secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers Ferguson, Stuart G.
 2009
 31 Part 2 p. 1957-1965
9 p.
 artikel
140 Probability of pharmacodynamic target attainment with standard and prolonged-infusion antibiotic regimens for empiric therapy in adults with hospital-acquired pneumonia Kim, Aryun
 2009
 31 Part 2 p. 2765-2778
14 p.
 artikel
141 Psychological interventions for reducing pain and distress during routine childhood immunizations: A systematic review Chambers, Christine T.
 2009
 31 Part 2 p. S77-S103
27 p.
 artikel
142 Psychosocial aspects of fabry disease and their impact on optimal disease management Mehta, Atul B.
 2009
 31 Part 2 p. S7-S8
2 p.
 artikel
143 Relative bioavailability of generic and branded 250-mg and 500-mg oral chlorphenesin carbamate tablets in healthy Korean volunteers: A single-dose, randomized-sequence, open-label, two-period crossover trial Yu, Ji-young
 2009
 31 Part 2 p. 2735-2743
9 p.
 artikel
144 Results of a retrospective claims database analysis of differences in antidepressant treatment persistence associated with escitalopram and other selective serotonin reuptake inhibitors in the United States Esposito, Dominick
 2009
 31 Part 2 p. 644-656
13 p.
 artikel
145 Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions Spínola, Ana Cristina Franco
 2009
 31 Part 2 p. 1992-2001
10 p.
 artikel
146 Results of a thematic analysis to explore the experiences of patients with schizophrenia taking antipsychotic medication Rofail, Diana
 2009
 31 Part 2 p. 1488-1496
9 p.
 artikel
147 Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations Friedman, Howard S.
 2009
 31 Part 2 p. 1056-1063
8 p.
 artikel
148 Retrospective cohort chart review study of factors associated with the development of thrombocytopenia in adult Japanese patients who received intravenous linezolid therapy Niwa, Takashi
 2009
 31 Part 2 p. 2126-2133
8 p.
 artikel
149 Review of the contemporary cytotoxic and biologic combinations available for the treatment of metastatic breast cancer Tkaczuk, Katherine H. Rak
 2009
 31 Part 2 p. 2273-2289
17 p.
 artikel
150 Risk for nocturnal hypoglycemia with biphasic insulin aspart 30 compared with biphasic human insulin 30 in adults with type 2 diabetes mellitus: A meta-analysis Davidson, Jaime A.
 2009
 31 Part 2 p. 1641-1651
11 p.
 artikel
151 Romiplostim in chronic immune thrombocytopenic purpura Cersosimo, Robert J.
 2009
 31 Part 2 p. 1887-1907
21 p.
 artikel
152 Self-reported sedation profile of immediate-release quetiapine fumarate compared with extended-release quetiapine fumarate during dose initiation: A randomized, double-blind, crossover study in healthy adult subjects Datto, Catherine
 2009
 31 Part 2 p. 492-502
11 p.
 artikel
153 Severe insulin allergy after percutaneous transluminal coronary angioplasty Wang, Chun
 2009
 31 Part 2 p. 569-574
6 p.
 artikel
154 Shifting the paradigm toward earlier treatment of multiple sclerosis with interferon beta Comi, Giancarlo
 2009
 31 Part 2 p. 1142-1157
16 p.
 artikel
155 Short-term adherence to β-blocker therapy among ethnic Chinese patients with hypertension: A cohort study Wong, Martin C.S.
 2009
 31 Part 2 p. 2170-2177
8 p.
 artikel
156 Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: A prospective, randomized, double-masked, active-controlled, three-period crossover pilot study Sonty, Sriram
 2009
 31 Part 2 p. 2063-2071
9 p.
 artikel
157 Silodosin: A selective α1A-adrenergic receptor antagonist for the treatment of benign prostatic hyperplasia Schilit, Sara
 2009
 31 Part 2 p. 2489-2502
14 p.
 artikel
158 Steady-state pharmacokinetics and tolerability of orally administered fampridine sustained-Release 10-mg tablets in patients with multiple sclerosis: A 2-week, open-label, follow-up study Vollmer, Timothy
 2009
 31 Part 2 p. 2215-2223
9 p.
 artikel
159 Tapentadol hydrochloride: A centrally acting oral analgesic Wade, William E.
 2009
 31 Part 2 p. 2804-2818
15 p.
 artikel
160 The effects of ketoconazole and rifampicin on the pharmacokinetics of mirodenafil in healthy Korean male volunteers: An open-label, one-sequence, three-period, three-treatment crossover study Shin, Kwang-Hee
 2009
 31 Part 2 p. 3009-3020
12 p.
 artikel
161 The efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults Najib, Jadwiga
 2009
 31 Part 2 p. 142-176
35 p.
 artikel
162 The role of patient inexperience in medication discontinuation: A retrospective analysis of medication nonpersistence in seven chronic illnesses Vanelli, Mark
 2009
 31 Part 2 p. 2628-2652
25 p.
 artikel
163 The thiazolidinediones rosiglitazone and pioglitazone and the risk of coronary heart disease: A retrospective cohort study using a US health insurance database Ziyadeh, Najat
 2009
 31 Part 2 p. 2665-2677
13 p.
 artikel
164 Tolerability of atypical antipsychotics in the treatment of adults with schizophrenia or bipolar disorder: A mixed treatment comparison of randomized controlled trials Edwards, Steven J.
 2009
 31 Part 2 p. 1345-1359
15 p.
 artikel
165 Tolerability of teicoplanin in 117 hospitalized adults with previous vancomycin-induced fever, rash, or neutropenia: A retrospective chart review Hung, Yuan-Pin
 2009
 31 Part 2 p. 1977-1986
10 p.
 artikel
166 Tolerability outcomes of a multicenter, observational, open-label, drug-surveillance study in patients with type 2 diabetes mellitus treated with pioglitazone for 2 years Grossman, Loren D.
 2009
 31 Part 2 p. 74-88
15 p.
 artikel
167 Treatment of depression in the elderly: A review of the recent literature on the efficacy of single- versus dual-action antidepressants Mukai, Yuki
 2009
 31 Part 2 p. 945-961
17 p.
 artikel
168 Two first-in-human, open-label, phase I dose-escalation safety trials of MEDI-528, a monoclonal antibody against interleukin-9, in healthy adult volunteers White, Barbara
 2009
 31 Part 2 p. 728-740
13 p.
 artikel
169 Upper gastrointestinal tolerability of alendronate sodium monohydrate 10 mg once daily in postmenopausal women: A 12-week, randomized, double-blind, placebo-controlled, exploratory study Adachi, Jonathan D.
 2009
 31 Part 2 p. 1747-1753
7 p.
 artikel
170 Validity of the adherence estimator in the prediction of 9-month persistence with medications prescribed for chronic diseases: A prospective analysis of data from pharmacy claims McHorney, Colleen A.
 2009
 31 Part 2 p. 2584-2607
24 p.
 artikel
171 Varenicline: A first-line treatment option for smoking cessation Garrison, Gina Daubney
 2009
 31 Part 2 p. 463-491
29 p.
 artikel
                             171 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland